公司资料
Acurx Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- ACXP
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.47 USD (+1.38%)
收盘价
最后更新: 2026年8月21日
7.74M USD
市值
股价为何变动
As of Aug 21, 2026, ACXP closed up 1.38% at $1.47. No new same-company headline was identified in the current news window.
公司概览
业务概览
Acurx Pharmaceuticals is an anti-infective company focused on novel antibiotics for bacterial infections. Its platform is aimed at addressing antibiotic resistance in difficult pathogens.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Acurx sits in specialty biopharma.
商业模式特征
The company depends on clinical data, anti-infective differentiation, and the commercial opportunity in resistant infections.
生物医药行业定位
Acurx is a niche anti-infective name whose valuation depends on regulatory and development progress.
未来催化剂
- Acurx’s catalysts are ibezapolstat and the recurrent C. difficile program, along with any regulatory or development step that keeps the oral-antibiotic story moving. The company remains highly dependent on clinical progress.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。